在LRRK2-链接帕金森病中细胞和细胞外微RNA失调
Felix Knab1, Jun-Hoe Lee2, Raja Nirujogi3
1Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany. felix.knab@uni-tuebingen.de.
Molecular neurobiology
|November 26, 2025
概括
无细胞微RNAs (miRNAs) 在帕金森病模型中显示出与LRRK2 G2019S突变的明显变化. 在患者脑脊液中检测到诱导多能干细胞衍生的神经元中的这些miRNA变化,这表明个性化生物标志物的潜力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物标志物发现发现
背景情况:
- 无细胞微RNA (miRNA) 是神经退行性疾病的新兴生物标志物.
- 散发性帕金森病 (PD) miRNAs的变化已知,但遗传形式,如LRRK2 G2019S突变,需要进一步调查.
- 了解基因PD中的无细胞miRNA变化对于开发向诊断至关重要.
研究的目的:
- 调查LRRK2 G2019S突变是否导致细胞内和细胞外miRNA配置文件的可检测变化.
- 为了确定体外识别的miRNA签名是否可以在患者衍生的脑脊液 (CSF) 中验证.
- 建立诱导的多能干细胞衍生的多巴胺基神经元作为在遗传性PD中识别无细胞miRNA生物标志物的模型.
主要方法:
- 从具有或没有LRRK2 G2019S突变的诱导多能干细胞中分化多巴胺基神经元.
- 从细胞培养基中分离出来的细胞外囊泡,用于无细胞miRNA分析.
- 进行了小RNA测序,RT-qPCR验证,并从LRRK2 G2019S患者和对照组的CSF中量化了候选miRNA.
主要成果:
- 成功地从人类多巴胺基神经元中分离出细胞外囊泡.
- 在细胞和无细胞RNA中识别出明显的差异表达的miRNAs,其中let-7g-5p和miR-21-5p在细胞和无细胞RNA中持续上调.
- 观察到这些miRNA变化反映在患者的脑脊液中,与体外发现相关,并支持患者特定的特征.
结论:
- 诱导多能干细胞衍生的多巴胺基神经元作为确定LRRK2 G2019S相关的无细胞miRNA特征的可行模型.
- 在体外检测到的miRNA失调被反映在患者的CSF中,表明它们作为可访问的生物标志物的潜力.
- 这些发现支持基因帕金森病的个性化生物标志物策略,需要在更大的队列中进一步验证.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953


